Concepts of toxicokinetic modeling and the relevance of toxicokinetics for understanding dose-response relationships, species scaling, and risk estimation are broached. A physiological one-compartment model for 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) is presented in detail. It describes the TCDD burden of the human body, which results from TCDD-contaminated food, in dependence of age. The model was validated using a series of measured values obtained by other authors and this group. They represent lipid-based concentrations of TCDD in liver, blood, adipose tissue, feces, and mother's milk in dependence of age. Special attention was paid to the TCDD burden in infants resulting from feeding with mother's milk or formula. Model simulations demonstrate that TCDD burden can amount to 10 mg/kg of lipids after nursing for 6 months with mother's milk exclusively This is still within the range of the concentrations found in adults. After the nursing period, TCDD burden declines. From the age of 7 years on, there is no longer a difference in the TCDD burden, independently of the food they had received as infants. According to the model, elimination half-life of TCDD from the body is not constant but increases during life starting from a few months in newborns to several years in adults.
Abraham, K., Krowke, R., and Neubert, D.1988. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1: dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Arch. Toxicol.62:359–368.
2.
Abraham, K., Hille, A., Ende, M., and Helge, H.1994a. Intake and fecal excretion of PCDDs, PCDFs, HCB and PCBs (138, 153, 180) in a breast-fed and a formula-fed infant. Chemosphere29:2279–2286.
3.
Abraham, K., Päpke, O., Ball, M., Lis, A., and Helge, H.1994b. Concentrations of PCDDs, PCDFs and coplanar PCBs in blood fat of a breast-fed and a formula-fed infant. Organohalogen Comp.21:163–165.
4.
Abraham, K., Steuerwald, U., Päpke, O., Ball, M., Lis, A., Weihe, P., and Helge, H.1995. Concentrations of PCDDs, PCDFs and PCBs in human perinatal samples from Faroe Islands and Berlin. Organohalogen Comp.26:213–218.
5.
Acker, L., Barke, E., Hapke, H.-J., Heeschen, W., Koransky, W., Kübler, W., and Reinhardt, D.1984. In DFG-Deutsche Forschungsgemeinschaft, Rückstände and Verunreinigungen in Frauenmilch, Mitteilung XII der Kommission zur Prüfung von Rückständen in Lebensmitteln. Weinheim: Verlag Chemie.
6.
Andersen, M. E., Mills, J. J., Gargas, M. L., Kedderis, L., Birnbaum, L. S., Neubert, D., and Greenlee, W. F.1993. Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. Risk Anal.13:25–36.
7.
Ayotte, P., Carrier, G., and Dewailly, E.1994. Health risk assessment for newborns exposed to organochlorine compounds through breast feeding. Organohalogen Comp.21:45–50.
8.
Beck, H., Eckart, K., Mathar, W., and Wittkowski, R.1987. Isomerspezifische Bestimmung von PCDD and PCDF in Human-und Lebensmittelproben. In Dioxin—eine technische, analytische, ökologische und toxikologische Herausforderung: Kolloquium Mannheim, 5/5-7/1987, VDI-Komm. Reinhaltung d. Luft, 634:359–382. Düsseldorf: VDI-Verlag, VDI-Berichte.
9.
Beck, H., Eckart, K., Mathar, W., and Wittkowski, R.1989. PCDD and PCDF body burden from food intake in the Federal Republic of Germany. Chemosphere18:417–424.
10.
Beck, H., Droß, A., Kleemann, W. J., and Mathar, W.1990. PCDD and PCDF concentrations in different organs from infants. Chemosphere20:903–910.
11.
Brouwer, A., Ahlborg, U. G., Van den Berg, M., Birnbaum, L. S., Boersma, E. R., Bosveld, B., Denison, M. S., Earl Gray, L., Hagmar, L., Holene, E., Huisman, M., Jacobson, S. W., Jacobson, J. L., Koopman-Esseboom, C., Koppe, J. G., Kulig, B. M., Morse, D. C., Muckle, G., Peterson, R. E., Sauer, P. J. J., Seegal, R. F,, Smits-Van Prooije, A. E., Touwen, B. C. L., Weisglas-Kuperus, N., and Winneke, G.1995. Functional aspects of developmental toxicity of polyhalo-genated aromatic hydrocarbons in experimental animals and human infants. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Section293:1–40.
12.
Carrier, G., Brunet, R. C., and Brodeur, J.1995a. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans, I: nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues. Toxicol. Appl. Pharmacol.131:253–266.
13.
Carrier, G., Brunet, R. C., and Brodeur, J.1995b. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans, II: kinetics of absorption and disposition of PCDDs/PCDFs. Toxicol. Appl. Pharmacol.131:267–276.
14.
Csan'dy, Gy. A., Mendrala, A. L., Nolan, R. J., and Filser, J. G.1994. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Arch. Toxicol.68:143–157.
15.
Documenta Geigy. 1975. Wissenschaftliche Tabellen, 7th ed., ed. K. Diem and C. Lentner. Stuttgart: Georg Thieme Verlag.
16.
Filser, J. G.1996. Toxikokinetik. In Toxikologie, ed. H. Greim, and E. Deml13–40. Weinheim: Vch Verlagsgesellschaft.
17.
Filser, J. G., Gans, G., Kreuzer, P. E., and Wuthe, J.1992. Ein auf physiologischen Parametern beruhendes pharmakokinetisches Modell zur Beschreibung der Belastung des Menschen mit 2,3,7,8-Tetrachlordibenzo-p-dioxin (TCDD) über die gesamte Lebenszeit, Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin e.V., 32. Jahrestagung, Köln 18.-21. 5, 617–621. Stuttgart: Genter Verlag.
18.
Filser, J. G., Csan'dy, Gy. A., Kreuzer, P. E., and Kessler, W.1995. Toxicokinetic models for volatile industrial chemicals and reactive metabolites. Toxicol. Lett.82/83:357–366.
19.
Filser, J. G., Greim, H., and Timm, J.1996. Risikoabschätzungen für krebserzeugende Stoffe. In Toxikologie, ed. H. Greim and E. Deml, 381–396. Weinheim: Vch Verlagsgesellschaft.
20.
Fürst, P., Krüger, C., Meemken, H.-A., and Groebel, W.1989. PCDD and PCDF levels in human milk: dependence on the period of lactation. Chemosphere18:439–444.
21.
Geyer, H. J., Scheunert, I., Filser, J. G., and Korte, F.1986. Bioconcentration potential (BCP) of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) in terrestrial organisms including humans. Chemosphere15:1495–1502.
22.
Greim, H., Deml, E., Mangelsdorf, I., and Sterzl-Eckert, H.1993. Untersuchung der Belastung der Bevölkerung in Schwandorf mit polychlorierten Dibenzodioxinen und Dibenzofuranen. Bayern, Germany: Bericht für die Regierung der Oberpfalz.
23.
International Commission on Radiological Protection (ICRP). 1975. No. 23 Report of the Task Group on Reference Man. Oxford: Pergamon Press.
24.
Jödicke, B., Ende, M., Helge, H., and Neubert, D.1992. Fecal excretion of PCDDs/PCDFs in a 3-month-old breast-fed infant. Chemosphere25:1061–1065.
25.
Kedderis, L. B., Andersen, M. E., and Birnbaum, L. S.1993. Effect of dose, time, and pretreatment on the biliary excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Fund. Appl. Toxicol.21:405–411.
26.
Kissel, J. C., and Robarge, G. M.1988. Assessing the elimination of 2,3,7,8-TCDD from humans with a physiologically based pharmacokinetic model. Chemosphere17:2017–2027.
27.
Körner, W., Dawidowsky, N., and Hagenmaier, H.1993. Fecal excretion rates of PCDDs and PCDFs in two breast-fed infants. Chemosphere27:157–162.
28.
Kreuzer, P. E., Csan'dy, Gy. A., Baur, C., Kessler, W., Päpke, O., Greim, H., and Filser, J. G.1997. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants: a toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch. Toxicol.71:383–400.
29.
Leitsätze zur Säuglingsernährung. 1984. Ernährungsplan für das 1: Lebensjahr, eds. G. Schöch, and F. Manz. Dortmund, Germany: Forschungsinstitut für Kinderernährung.
30.
Leung, H-W., Ku, R. H., Paustenbach, D. J., and Andersen, M. E.1988. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Toxicol. Lett.42:15–28.
31.
Leung, H-W., Paustenbach, D. J., Murray, F. J., and Andersen, M. E.1990a. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicol. Appl. Pharmacol.103:399–410.
32.
Leung, H-W., Poland, A., Paustenbach, D. J., Murray, F. J., and Andersen, M. E.1990b. Pharmacokinetics of [125I]-2-Iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: analysis with a physiological modeling approach. Toxicol. Appl. Pharmacol.103:411–419.
33.
Lovell, D. P.1988. Risk assessment of chemicals. In Experimental Toxicology, ed. D. Anderson and D. M. Conning, 414–435. London: Royal Society of Chemistry.
34.
McLachlan, M. S.1993. Digestive tract absorption of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in a nursing infant. Tox. Appl. Pharmacol.123:68–72.
35.
Needham, L. L., Patterson, D. G., and Houk, V. N.1991. Levels of TCDD in selected human populations and their relevance to human risk assessment. In Banbury Report 35: Biological Basis for Risk Assessment of Dioxins and Related Compounds, ed. M. A. Gallo, R. J. Scheuplein, and K. A. Van der Heijden, 229–257. New York: Cold Spring Harbor Laboratory Press.
36.
Päpke, O., Ball, M., and Lis, A.1994. PCDD/PCDF in humans, a 1993-update of background data. Chemosphere29:2355–2360.
37.
Poiger, H., and Schlatter, C.1979. Biological degradation of TCDD in rats. Nature281:706–707.
38.
Poiger, H., and Schlatter, C.1986. Pharmacokinetics of 2,3,7,8-TCDD in man. Chemosphere15:1489–1494.
39.
Ramsey, J. C., Hefner, J. G., Karbowski, R. J., Braun, W. H., and Gehring, P. J.1982. The in vivo biotransformation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat. Toxicol. Appl. Pharmacol.65:180–184.
40.
Rappe, C., and Andersson, R.1992. Levels of PCDDs and PCDFs in human feces. Organohalogen Comp.9:195–198.
41.
Schecter, A., Päpke, O., and Ball, M.1990. Evidence for transplacental transfer of dioxins from mother to fetus: chlorinated dioxin and dibenzofuran levels in the livers of stillborn infants. Chemosphere21:1017–1022.
42.
Schlatter, C., and Poiger, H.1989. Chlorierte dibenzodioxine und dibenzo-furane (PCDDs/PCDFs): belastung und gesundheitliche beurteilung. Z. Umweltchem. Ökotox.2:11–17.
43.
Thoma, H.1989. Polychloridibenzo-p-dioxine und polychlordibenzofurane in humanproben. Z. Umweltchem. Ökotox.1:25–26.
44.
Thoma, H., Mücke, W., and Kretschmer E.1989. Concentrations of PCDD and PCDF in human fat and liver samples. Chemosphere18:491–498.
45.
Thoma, H., Mücke, W., and Kauert, G.1990. Comparison of the polychlorinated dibenzo-p-dioxin and dibenzofuran in human tissue and human liver. Chemosphere20:433–442.
46.
Van der Molen, G. W., Kooijman, S. A. L. M., and Slob, W.1996. A generic toxicokinetic model for persistent lipophilic compounds in humans: an application to TCDD. Fund. Appl. Toxicol.31:83–94.
47.
Weber, L. W. D., Ernst, S. W., Stahl, B. U., and Rozman, K.1993. Tissue distribution and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats after intravenous injection. Fund. Appl. Toxicol.21:523–534.
48.
Wendling, J. M., Orth, R. G., and Poiger, H.1990. Determination of [3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin in human feces to ascertain its relative metabolism in man. Anal. Chem.62:796–800.
